Showing results (61-70 of 401) with videos related to
Sort By:
Pageof 41
Trials|October 11, 2012
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approachStephen Wright, Paul Duncombe, Douglas G AltmanStatistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomesFrançois Curtin, Diana Elbourne, Douglas G AltmanEuropean Radiology|January 21, 2015
Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approachSteve Halligan, Douglas G Altman, Susan MallettStatistics in Medicine|October 12, 2005
Dichotomizing continuous predictors in multiple regression: a bad ideaPatrick Royston, Douglas G Altman, Willi SauerbreiMaturitas|March 24, 2012
Reporting clinical research: guidance to encourage accurate and transparent research reportingIveta Simera, Shona Kirtley, Douglas G AltmanStatistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomesFrançois Curtin, Douglas G Altman, Diana ElbourneTrends in Molecular Medicine|November 6, 2007
Quiet mutations in inbred strains of miceJames C Stevens, Gareth T Banks, Michael F W Festing, et al.Clinical Oral Investigations|April 4, 2003
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsDavid Moher, Kenneth F Schulz, Douglas G Altman, et al.Statistics in Medicine|August 21, 2012
Improving the reporting of randomised trials: the CONSORT Statement and beyondDouglas G Altman, David Moher, Kenneth F SchulzAnnals of Internal Medicine|March 26, 2010
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trialsKenneth F Schulz, Douglas G Altman, David Moher, et al.Pageof 41